Watch CBS News

French biotech company opens US headquarters in Pittsburgh to begin clinical trials on diabetes drug

A French biotech company developing a new type 2 diabetes drug is opening its American headquarters in Pittsburgh. KDKA money editor Jon Delano spoke with the company's chairman on Monday afternoon to find out what this all means.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.